title: Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
abstract: BACKGROUND
  Sensitive detection and qualitative analysis of atherosclerotic plaques are in high demand in cardiovascular clinical settings. The leukocyte-endothelial interaction mediated by an adhesion molecule P-selectin participates in arterial wall inflammation and atherosclerosis.
  
  
  RESULTS
  A (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugated anti-P-selectin monoclonal antibody ((64)Cu-DOTA-anti-P-selectin mAb) probe was prepared by conjugating an anti-P-selectin monoclonal antibody with DOTA followed by (64)Cu labeling. Thirty-six hours prior to PET and CT fusion imaging, 3MBq of (64)Cu-DOTA-anti-P-selectin mAb was intravenously injected into low density lipoprotein receptor-deficient Ldlr-/- mice. After a 180min PET scan, autoradiography and biodistribution of (64)Cu-DOTA-anti-P-selectin monoclonal antibody was examined using excised aortas. In Ldlr-/- mice fed with a high cholesterol diet for promotion of atherosclerotic plaque development, PET and CT fusion imaging revealed selective and prominent accumulation of the probe in the aortic root. Autoradiography of aortas that demonstrated probe uptake into atherosclerotic plaques was confirmed by Oil red O staining for lipid droplets. In Ldlr-/- mice fed with a chow diet to develop mild atherosclerotic plaques, probe accumulation was barely detectable in the aortic root on PET and CT fusion imaging. Probe biodistribution in aortas was 6.6-fold higher in Ldlr-/- mice fed with a high cholesterol diet than in those fed with a normal chow diet. (64)Cu-DOTA-anti-P-selectin mAb accumulated selectively in aortic atherosclerotic plaques and was detectable by PET and CT fusion imaging in Ldlr-/- mice.
  
  
  CONCLUSIONS
  P-selectin is a candidate target molecule for early-phase detection by PET and CT fusion imaging of atherosclerotic plaques.
authors.affiliation: RIKEN Center for Molecular Imaging Science, Kobe, Japan. nakamuri@riken.jp
authors.forename: Ikuko
authors.initials: I
authors.lastname: Nakamura
authors.forename: Koki
authors.initials: K
authors.lastname: Hasegawa
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Wada
authors.forename: Tetsuaki
authors.initials: T
authors.lastname: Hirase
authors.forename: Koichi
authors.initials: K
authors.lastname: Node
authors.forename: Yasuyoshi
authors.initials: Y
authors.lastname: Watanabe
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D001011:Aorta / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D001345:Autoradiography; D015415:Biomarkers / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D003301:Copper Radioisotopes; D004195:Disease Models, Animal; D042241:Early Diagnosis; D006573:Heterocyclic Compounds, 1-Ring; D051379:Mice; D018345:Mice, Knockout; D064847:Multimodal Imaging; D019007:P-Selectin / Q000276:immunology / Q000378:metabolism*; D058226:Plaque, Atherosclerotic / Q000000981:diagnostic imaging* / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D011973:Receptors, LDL / Q000172:deficiency* / Q000235:genetics; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D002791:Cholesterol, Dietary; D003301:Copper Radioisotopes; D006573:Heterocyclic Compounds, 1-Ring; D019007:P-Selectin; D019275:Radiopharmaceuticals; D011973:Receptors, LDL; C071349:1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid